Sylogent continues to take its software products to pharmaceutical events around the world. Company CEO Jack Yeager also speaks at many of these events (*).

APRIL 27-99: Arlington, VA- ISMPP Publication Planning Annual Meeting*

JUNE 22-23: Brussels, Belgium - Publications & Data Disclosure

AUGUST 25-26: Philadelphia, PA - Clinical Systems & Technology Marketplace

February 9-10, 2015

San Diego, California- Defining the Role of Publication Planning in an Increasingly Global, Transparent and Data-Driven World

The 14th Annual International Publication Planning Meeting brings together a variety of players involved in the publication planning process- from pub planners to medical writers to physicians & academia to medical journals- to discuss current issues surrounding pharmaceutical pub planning. Our renowned meetings provide a venue that promotes lively and constructive discourse on a wide range of issues affecting the pub planning environment. Roll up your sleeves, ask daring questions, hear innovative solutions, and walk away with tangible tools that you can apply right away in your publication planning department.

We explore ideas like: - How the Sunshine Act has changed the way pub planning departments do business - How to tackle the challenges posed by new transparency and data sharing guidelines - Which current trends in pharma are having an impact on pub planning - How to make the biggest impact with your publications in the face of time & budgeting constraints - The new role of medical journals and how they drive submissions and publications.


February 5-6, 2015

Philadelphia, PA- Navigating Patient-Level Data Disclosure, EudraCT and International Registries

As the most comprehensive event of its kind, senior level executives convene to discuss implications of and approaches for data sharing, ensuring compliance with regulations, navigating disclosure requirements and releasing patient-level data. Ensure your organization is prepared to meet the requirements and pressures of increased disclosure and transparency of clinical trial data.

January 21-21, 2015

Arlington, VA - Best Practices to Enhance TMF Collection, Monitoring, Utilization, Quality and Archiving While Remaining Compliant for Audits and Inspections.

Regulators worldwide require sponsor companies to assemble a comprehensive Trial Master File during clinical trials. This means filing and maintaining hundreds of thousands of clinical documentation. This is important both for the patient and for the sponsor companies to ensure they are ready for inspection and that GCP guidance's are being followed.

In recent years, there has been much discussion regarding what documents should be included in TMF and how to make the switch to an eTMF system, which could result in greater ease of archiving for TMF professionals. While implementing eTMF can be costly and training employees can be difficult, through eTMF you can ensure real-time monitoring of data to ensure data. This will result in better management of CRO partners and ease the inspection process for sponsor companies.

TMF experts will discuss best practices for developing, managing and monitoring a TMF process that is regulatory compliant for audits and inspections. TMF Process Owners, Quality Assurance, Clinical, Regulatory and Information Technology professionals who are responsible for TMF will share insights and best practices to facilitate successful TMF management.

January 20-21, 2015

London, UK - Medical Publications for Better Patient Care: Integrity, Innovation, and Impact

December 11-12, 2014

Philadelphia, PA- Navigating Patient-Level Data Disclosure, EudraCT and International Registries

As the most comprehensive event of its kind, senior level executives convene to discuss implications of and approaches for data sharing, ensuring compliance with regulations, navigating disclosure requirements and releasing patient-level data. Ensure your organization is prepared to meet the requirements and pressures of increased disclosure and transparency of clinical trial data.

September 23-25, 2014

London Kensington, UK- Clinical Trial Disclosure: Towards a More Transparent World

New EU requirements are expected to come into force during 2014, impacting clinical trial processes including informed consent as well as the provision of public access to information and results of clinical trials. This workshop will review the new transparency requirements and voluntary commitments and, describe how these will impact current disclosure procedures. There will be a focus on sharing experiences on how the requirements are being implemented in practice.

The two day workshop will address the Transparency aspects of the new Clinical Trials Regulation expected to become applicable in 2016, the EMA clinical data transparency policy expected to be published in its final version for implementation later in 2014, and implementation of the clinical trials results submission to EudraCT for public disclosure via the EU Clinical Trials Register. The EU results requirements via EudraCT are to come in force by the finalization of the next version update of EudraCT, expected mid-2014. The workshop will also address how these initiatives relate to the EFPIA-PhRMA "Principles for Responsible Data Sharing"" and how industry is implementing the Principles.

An adjacent 2-day workshop on the new Clinical Trials Regulation, will offer an opportunity for attendees to focus on conceptual and practical aspects of implementation of the new Regulation. Attendees can participate in either one workshop or in the entire 3-day program. The two workshops will overlap with a day addressing the Transparency aspects of the Clinical Trials Regulation.

June 15-19, 2014

San Diego, CA - Celebrate the Past - Invent the Future

This year marks the 50th Anniversary of the DIA Annual Meeting, the largest multidisciplinary event that brings together a global network of life sciences professionals to foster innovation that will lead to the development of safe and effective medical products and therapies to patients.

Provide a global unbiased platform to raise the level of discussion to facilitate innovation that will change the future of health care Provide comprehensive coverage of the full development and life cycle management of process for all health care products Offer a holistic and integrated approach to the development life cycle management of regulated health care products.

June 9-10, 2014

Dublin, Ireland- Effectively Align the Dissemination of Study Data through Results Postings and Publications

With the more stringent focus on posting results publicly, it is a necessity that the registration process, results release, report writing and publication are aligned. As companies prepare to post study results to the EudraCT database, commit to sharing patient-level data with third party researchers and redefine publication strategies, internal teams are tasked with ensuring consistent messaging in protocols, clinical study reports, summaries, registries and publications, all while remaining compliant with changing regulations.

This is the only global life sciences congress that convenes publication planning and clinical trial disclosure professionals to share how to best coordinate results postings in registries and journals.

April 7-9, 2014

Arlington, VA - Leading through Collaboration

ISMPP Annual Meeting focused on the important theme of collaboration - how we can all "work smarter" together in promoting a culture of ethical practice, trust, Openness, and sharing. Collaborations within the publication planning arena were under the spotlight, as were new and innovative collaborations between Pharma and other valued partners.

March 24-25, 2014

Princeton, NJ - Enhance scientific exchange through digital access, data disclosure and innovative partnerships

For the 9th straight year, this conference brings together leaders in medical publishing to discuss best practices for successful strategic publication planning

Understanding the demands of increased transparency
Using new technology in disseminating information
Navigating processes under a CIA
Assessing the value of publications
Integrating health outcomes into pub planning
Developing strategies for global planning

February 10-11, 2014

San Diego, California - Enhance scientific exchange through digital access, data disclosure and innovative partnerships

For the 9th straight year, this conference brings together leaders in medical publishing to discuss best practices for successful strategic publication planning

Understanding the demands of increased transparency
Using new technology in disseminating information
Navigating processes under a CIA
Assessing the value of publications
Integrating health outcomes into pub planning
Developing strategies for global planning

February 4-6, 2014

Miami, Florida - Enhance scientific exchange through digital access, data disclosure and innovative partnerships

For the 9th straight year, this conference brings together leaders in medical publishing to discuss best practices for successful strategic publication planning

Understanding the demands of increased transparency
Using new technology in disseminating information
Navigating processes under a CIA
Assessing the value of publications
Integrating health outcomes into pub planning
Developing strategies for global planning

January 21-22, 2014

LONDON, ENGLAND - Enhance scientific exchange through digital access, data disclosure and innovative partnerships

For the 9th straight year, this conference brings together leaders in medical publishing to discuss best practices for successful strategic publication planning

Understanding the demands of increased transparency
Using new technology in disseminating information
Navigating processes under a CIA
Assessing the value of publications
Integrating health outcomes into pub planning
Developing strategies for global planning

December 9-10, 2013

PHILADELPHIA, PA - Enhance scientific exchange through digital access, data disclosure and innovative partnerships

For the 9th straight year, this conference brings together leaders in medical publishing to discuss best practices for successful strategic publication planning

Understanding the demands of increased transparency
Using new technology in disseminating information
Navigating processes under a CIA
Assessing the value of publications
Integrating health outcomes into pub planning
Developing strategies for global planning

November 4-5, 2013

PHILADELPHIA, PA - Overcome barriers for KOL identification, access, compensation and reporting

This senior level summit focuses on the most pressing challenges facing medical affairs teams around building effective, sustainable and compliant relationships with HCPs and key opinion leaders in light of strict regulatory enforcement that is “tying the hands” of both industry professionals and healthcare providers.

Reporting issues associated with the Sunshine Act and the intricacies of tracking and documenting data
Managing aggregate spend limits set by the company
Coordinating medical affairs and compliance teams for reporting HCP spend
Interfacing with new, non-traditional opinion leaders from private payers, physician groups and the government
Increasingly restrictive access barriers
Educating HCPs on Sunshine and FMV guidelines
HCP identification, relationship development and mapping
Innovations in engagement and advances in technological tools
Developing effective HCP advocacy in support of a strategic brand plan

October 1-2, 2013

BETHESDA, MD - Different mechanisms for transparency, their scope, objectives, and audiences

Increased transparency changes availability and use of information from clinical trials, and brings with it new data use opportunities and operational challenges for industry and academia.

Identifying the current clinical trial disclosure requirements in the US and Europe Discussing the interrelationships between medical writing, regulatory affairs, and clinical trials disclosure teams to maintain consistency for protocol registration and results reporting Understanding the impact of greater transparency in the clinical trial disclosure environment on industry and academia Learning the advantages and implications of availability of clinical trial disclosure databases

September 19-20, 2013

SAN FRANCISCO, CA - Deliver Impactful Information and Monitor Compliance in a Patient Empowered Era

Pharmaceutical medical affairs teams overcome unclear standards for transparency and regulatory compliance to deliver impactful scientific information CBI's Medical Communications and Information Summit delivers best practices and SOPs vital to the compliant, accurate and impactful delivery of medical information. >

Knowing the latest in CIAs and how these agreements impact HCP interactions
Understanding how litigation trends and the Sunshine Act impact medical
communications
Compliantly connecting with patients and healthcare providers through social media, apps and the web
Identifying strategies to make the most of a REMS and post-market commitments

June 24-26, 2013

BOSTON, MA - DIA 2013 49th Annual Meeting

DIA 2013 49th Annual Meeting is the largest multidisciplinary event for professionals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices, and related products. The events anticipates 7,000+ attendees for the largest multidisciplinary event that brings together a global network of professionals to foster innovation that will lead to the development of safe and effective medical products and therapies to patients.

The Annual Meeting provides an invaluable forum for professionals involved in the discovery, development, and life-cycle management of pharmaceuticals, medical devices, and related products, including discussion of current and evolving areas such as comparative effectiveness research, health outcomes, and drug/device combination products.

June 12-13, 2013

CHICAGO, IL - Streamline Internal Processes, Maintain Compliance and Increase Audience Engagement in Speaker Programs

Increased transparency changes availability and use of information from clinical trials, and brings with it new data use opportunities and operational challenges for industry and academia.

For the 11th straight year, this conference brings together leaders in medical publishing to discuss best practices for successful strategic publication planning. Transparency has never been more demanding and this conference continues to keep all publication planning teams up to speed on how their policies align with the changing external environment. Attend this conference to understand how evolving regulations, new media considerations and the global industry climate impact your publication planning initiatives.

Demands of increased transparency
Use of new technology in disseminating information
Navigating processes under a CIA
Assessing the value of publications
Integrating health outcomes into pub planning
Strategies for global planning

June 11-12, 2013

DUBLIN, IRL - 2nd Annual Forum on Global Publication Planning and Clinical Trial Registries Strategies for Effective and Compliant Data Disclosure and Dissemination

The EMA recently announced that companies will be required to publish their clinical trials data starting January 1, 2014, making the raw data available to third party researchers and investigators. This marks one of the biggest developments around public disclosure and sharing of data. The mandate leaves many questions – what are the implications for global competitiveness, re-analysis of data, patient confidentiality, publication and data transparency? Attend this highly anticipated forum to learn more about how professionals working in publication planning and clinical trial disclosure can coordinate data sharing to ensure transparency.

Results posting/disclosure on the EudraCT database
Posting results for unapproved drugs
The European Commission’s proposed new Clinical Trial Regulation
Evolving EudraCT and Clinicaltrials.gov regulations
The editor perspective on working with industry
Collaboration between the disclosure and medical writing groups
Emerging development of local and national registries

April 29 - May 1, 2013

BALTIMORE, MD - Empowering The Medical Publication Community To Advance The Profession

We are excited to present the program for the 9th Annual Meeting of ISMPP, Empowering the Medical Publication Community to Advance the Profession. Science is advancing daily, the way in which information is analyzed and transmitted to end-users continues to evolve, and global collaborations are ever present. Consequently, continuous examination and improvement of the standards that guide scientific and medical data dissemination are crucial.

So how do we “empower” our profession? Through education and open exchange, particularly with diverse stakeholders, including emerging markets and academia. The 9th Annual Meeting will expose you to these and other groups and equip you with the knowledge and practical tools to work globally, build better relationships and find commonalities with all stakeholder groups, as well as understand the impact of phenomena such as “Big Data,” increased data sharing between pharma and researchers and real-world data, among others.